Kitchener, Ontario – March 11, 2026, Medical Innovation Xchange (MIX) is pleased to welcome DIA Labs Canada as the newest affiliate member in our expanding community of med‑tech innovators. DIA Labs joins MIX at a defining moment in their growth, bringing a mission‑driven approach to accessible respiratory health and a commitment to strengthening Ontario’s life sciences ecosystem.
DIA Labs Canada is a medical device manufacturer specializing in low‑cost, easy‑to‑use health technologies. Their flagship product under development, AirSense, is a novel Class II continuous asthma‑monitoring device designed to track respiratory patterns for up to 14 days. With millions of people living with asthma worldwide, AirSense aims to provide a more proactive, data‑driven approach to respiratory care.
By joining MIX, DIA Labs gains access to a peer community of founders who understand the realities of building, validating, and scaling regulated medical technologies in Canada. For DIA Labs, the decision to join MIX was rooted in a shared commitment to strengthening Ontario’s med‑tech sector.
“We believe MIX is helping companies strengthen Ontario’s life sciences ecosystem, and it truly feels like a missing link the sector has needed. DIA Labs was born in ON. We want to stay in ON.”
The team at DIA Labs is particularly excited about the collaborative opportunities ahead. With deep experience in clinical trials, they see MIX as a place where their expertise can support and be supported by other organizations navigating similar challenges.
“We’re excited to connect with other companies and share resources and ideas. Our team brings extensive clinical trial experience, and we believe that expertise can support many of the organizations at MIX.”
As DIA Labs advances AirSense toward broader validation and future clinical deployment, MIX looks forward to supporting their journey and amplifying their impact on respiratory health innovation.
We’re thrilled to welcome DIA Labs Canada to the MIX community as they continue developing accessible, scalable technologies that improve patient lives. Their mission aligns strongly with MIX’s vision for a thriving, founder‑driven med‑tech ecosystem.
To learn more about DIA labs, visit their website here, or to join MIX, visit MIX Programs.
